| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-02-07 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.350 | 0.350 | 0.0000 | ||||
| REV | 185.050M | 179.954M | -5.096M |
| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
You can purchase shares of HealthEquity (NASDAQ: HQY) through any online brokerage.
Other companies in HealthEquity’s space includes: Humana (NYSE:HUM), Molina Healthcare (NYSE:MOH), Progyny (NASDAQ:PGNY), Triple-S Management (NYSE:GTS) and Anthem (NYSE:ANTM).
The latest price target for HealthEquity (NASDAQ: HQY) was reported by JP Morgan on December 21, 2021. The analyst firm set a price target for 56.00 expecting HQY to rise to within 12 months (a possible 12.07% upside). 15 analyst firms have reported ratings in the last year.
The stock price for HealthEquity (NASDAQ: HQY) is $49.97 last updated Fri Jan 21 2022 21:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for HealthEquity.
HealthEquity’s $Q4 earnings are confirmed for after-market on February 7, 2022.
There is no upcoming split for HealthEquity.
HealthEquity is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.